Dr. Wagner-Johnston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5255 Loughboro Road Northwest
Washington, DC 20016Phone+1 202-660-6500Fax+1 202-660-6501
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
- University of ChicagoResidency, Internal Medicine, 2003 - 2005
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003
Certifications & Licensure
- MD State Medical License 2005 - 2025
- DC State Medical License 2022 - 2024
- PA State Medical License 2024 - 2024
- MO State Medical License 2008 - 2016
- IL State Medical License 2003 - 2006
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma Start of enrollment: 2009 Aug 01
- Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue Start of enrollment: 2010 Mar 01
- Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 58 citationsEfficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 studyGilles Salles, Stephen J. Schuster, Sven de Vos, Nina D. Wagner-Johnston, Andreas Viardot
Haematologica. 2017-04-01 - 425 citationsPrevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline updateCharles L. Loprinzi, Christina Lacchetti, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan
Journal of Clinical Oncology. 2020-07-14 - 220 citationsLong-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, ph...Stephen J. Schuster, Constantine S. Tam, Peter Borchmann, Nina Worel, Joseph P. McGuirk
The Lancet. Oncology. 2021-10-01
Abstracts/Posters
- A Phase IB Study of Blinatumomab (blina) in Patients with B Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or M...Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Pat...Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 PatientsNina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/ Waldenstrom's Macroglobulinemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Treatment Options in MCL: What Are the Best Practices?September 12th, 2024
- Pain PointersJune 1st, 2021
- Dual Expression of MYC, BCL2 Associated with Poorer Outcomes in DLBCLMay 26th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: